Literature DB >> 19191305

Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient.

Steven J Shook1, Erik P Pioro.   

Abstract

Recognition of the early symptoms and signs in amyotrophic lateral sclerosis, exclusion of alternative diagnoses, and referral to a tertiary center can have a significant positive impact on the lives of patients and their caregivers. This article provides the most current amyotrophic lateral sclerosis criteria, as well as helpful clinical clues to the diagnosis. An approach to laboratory testing, electrodiagnostic testing, and imaging to exclude diseases that mimic ALS also are discussed, as are atypical presentations that can confound timely diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19191305     DOI: 10.1002/ana.21545

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Bringing SOD1 into the fold.

Authors:  Sami Barmada; Steven Finkbeiner
Journal:  Nat Neurosci       Date:  2010-11       Impact factor: 24.884

2.  Peripheral nerve and muscle ultrasound in amyotrophic lateral sclerosis.

Authors:  Michael S Cartwright; Francis O Walker; Leah P Griffin; James B Caress
Journal:  Muscle Nerve       Date:  2011-08-03       Impact factor: 3.217

3.  Inhibition of Cytohesins Protects against Genetic Models of Motor Neuron Disease.

Authors:  Jinbin Zhai; Lei Zhang; Jelena Mojsilovic-Petrovic; Xiaoying Jian; Jeffrey Thomas; Kengo Homma; Anton Schmitz; Michael Famulok; Hidenori Ichijo; Yair Argon; Paul A Randazzo; Robert G Kalb
Journal:  J Neurosci       Date:  2015-06-17       Impact factor: 6.167

4.  A three-groups model for high-throughput survival screens.

Authors:  Benjamin A Shaby; Gaia Skibinski; Michael Ando; Eva S LaDow; Steven Finkbeiner
Journal:  Biometrics       Date:  2016-01-28       Impact factor: 2.571

5.  A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study.

Authors:  Paola Pierucci; Gennaro M Lenato; Patrizia Suppressa; Patrizia Lastella; Vincenzo Triggiani; Raffaella Valerio; Mario Comelli; Daniela Salvante; Alessandro Stella; Nicoletta Resta; Giancarlo Logroscino; Francesco Resta; Carlo Sabbà
Journal:  Orphanet J Rare Dis       Date:  2012-06-07       Impact factor: 4.123

6.  Delayed administration of VEGF rescues spinal motor neurons from death with a short effective time frame in excitotoxic experimental models in vivo.

Authors:  Luis B Tovar-y-Romo; Ricardo Tapia
Journal:  ASN Neuro       Date:  2012-03-27       Impact factor: 4.146

Review 7.  Trophic factors as modulators of motor neuron physiology and survival: implications for ALS therapy.

Authors:  Luis B Tovar-Y-Romo; Uri Nimrod Ramírez-Jarquín; Rafael Lazo-Gómez; Ricardo Tapia
Journal:  Front Cell Neurosci       Date:  2014-02-28       Impact factor: 5.505

8.  Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010-2015.

Authors:  Jaime Raymond; BjÖrn Oskarsson; Paul Mehta; Kevin Horton
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-05-26       Impact factor: 4.092

9.  Brain white matter shape changes in amyotrophic lateral sclerosis (ALS): a fractal dimension study.

Authors:  Venkateswaran Rajagopalan; Zao Liu; Didier Allexandre; Luduan Zhang; Xiao-Feng Wang; Erik P Pioro; Guang H Yue
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

10.  Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research.

Authors:  Beatriz Grisolia Araujo; Luiz Felipe Souza E Silva; Jorge Luiz de Barros Torresi; Amanda Siena; Berenice Cataldo Oliveira Valerio; Mariana Dutra Brito; Tatiana Rosado Rosenstock
Journal:  Mol Neurobiol       Date:  2020-08-25       Impact factor: 5.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.